Tarsus Pharmaceuticals (TARS) Return on Assets (2020 - 2026)

Tarsus Pharmaceuticals' Return on Assets history runs 7 years deep, the most recent figure standing at 0.0% for Q1 2026.

• In Q1 2026, Return on Assets changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Assets was 0.0% for Q1 2026 at Tarsus Pharmaceuticals, up from 0.0% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.0% in Q1 2026 to a low of 0.01% in Q4 2023.
• Historically, Return on Assets has averaged 0.0% across 5 years, with a median of 0.0% in 2022.
• Biggest YoY gain for Return on Assets was 0 bps in 2022; the steepest drop was 0 bps in 2022.
• A 5-year view of Return on Assets shows it stood at 0.0% in 2022, then tumbled by 93 bps to 0.01% in 2023, then jumped by 41 bps to 0.0% in 2024, then soared by 61 bps to 0.0% in 2025, then surged by 31 bps to 0.0% in 2026.
• The last three Return on Assets figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.